Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark J Dunning

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Plos Computational Biology|May 13, 2021
Fostering accessible online education using Galaxy as an e-learning platformBeatriz Serrano-Solano, Melanie C Föll, Cristóbal Gallardo-Alba, et al.
Genome Biology|October 10, 2007
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeCherie Blenkiron, Leonard D Goldstein, Natalie P Thorne, et al.
Science Translational Medicine|October 27, 2012
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profilingYinyin Yuan, Henrik Failmezger, Oscar M Rueda, et al.
Nature|January 6, 2012
Differential oestrogen receptor binding is associated with clinical outcome in breast cancerCaryn S Ross-Innes, Rory Stark, Andrew E Teschendorff, et al.
Endocrine-Related Cancer|January 7, 2015
HES5 silencing is an early and recurrent change in prostate tumourigenesisCharles E Massie, Inmaculada Spiteri, Helen Ross-Adams, et al.
The Journal of Pathology|November 15, 2018
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancerJules A Westbrook, Steven L Wood, David A Cairns, et al.
The New England Journal of Medicine|March 15, 2013
Analysis of circulating tumor DNA to monitor metastatic breast cancerSarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, et al.
Nature Genetics|March 8, 2016
Gene regulatory mechanisms underpinning prostate cancer susceptibilityThomas Whitington, Ping Gao, Wei Song, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2023
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseThomas Payne, Matthew Appleby, Ellen Buckley, et al.
Genome Biology|April 9, 2015
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancerSantiago Uribe-Lewis, Rory Stark, Thomas Carroll, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Plos Computational Biology|May 13, 2021
Fostering accessible online education using Galaxy as an e-learning platformBeatriz Serrano-Solano, Melanie C Föll, Cristóbal Gallardo-Alba, et al.
Genome Biology|October 10, 2007
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtypeCherie Blenkiron, Leonard D Goldstein, Natalie P Thorne, et al.
Science Translational Medicine|October 27, 2012
Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profilingYinyin Yuan, Henrik Failmezger, Oscar M Rueda, et al.
Nature|January 6, 2012
Differential oestrogen receptor binding is associated with clinical outcome in breast cancerCaryn S Ross-Innes, Rory Stark, Andrew E Teschendorff, et al.
Endocrine-Related Cancer|January 7, 2015
HES5 silencing is an early and recurrent change in prostate tumourigenesisCharles E Massie, Inmaculada Spiteri, Helen Ross-Adams, et al.
The Journal of Pathology|November 15, 2018
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancerJules A Westbrook, Steven L Wood, David A Cairns, et al.
The New England Journal of Medicine|March 15, 2013
Analysis of circulating tumor DNA to monitor metastatic breast cancerSarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, et al.
Nature Genetics|March 8, 2016
Gene regulatory mechanisms underpinning prostate cancer susceptibilityThomas Whitington, Ping Gao, Wei Song, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2023
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseThomas Payne, Matthew Appleby, Ellen Buckley, et al.
Genome Biology|April 9, 2015
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancerSantiago Uribe-Lewis, Rory Stark, Thomas Carroll, et al.
Pageof 5